{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:47:57Z","timestamp":1784742477036,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["surgpath.theclinics.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.path.2024.04.006","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T19:10:14Z","timestamp":1718478614000},"page":"431-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cervical Human Papillomavirus Testing"],"prefix":"10.1016","volume":"17","author":[{"given":"Carol N.","family":"Rizkalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.path.2024.04.006_bib1","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.path.2024.04.006_bib2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ajog.2015.10.147","article-title":"Cervical cancer screening: evidence behind the guidelines","volume":"214","author":"Lees","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"17","key":"10.1016\/j.path.2024.04.006_bib3","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1042\/CS20160786","article-title":"The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review","volume":"131","author":"Graham","year":"2017","journal-title":"Clin Sci"},{"issue":"1","key":"10.1016\/j.path.2024.04.006_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J\u00a0Pathol"},{"issue":"5","key":"10.1016\/j.path.2024.04.006_bib5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jasc.2019.06.001","article-title":"A\u00a0review of the FDA-approved molecular testing platforms for human papillomavirus","volume":"8","author":"Salazar","year":"2019","journal-title":"J\u00a0Am Soc Cytopathol"},{"issue":"5","key":"10.1016\/j.path.2024.04.006_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3322\/caac.21628","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.path.2024.04.006_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J\u00a0Low Genit Tract Dis"},{"issue":"9","key":"10.1016\/j.path.2024.04.006_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.path.2024.04.006_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4132\/jptm.2019.11.29","article-title":"Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution","volume":"54","author":"Kang","year":"2020","journal-title":"J\u00a0Pathol Transl Med"},{"issue":"5","key":"10.1016\/j.path.2024.04.006_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cncy.21687","article-title":"Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions","volume":"124","author":"Zhou","year":"2016","journal-title":"Cancer Cytopathol"},{"issue":"5","key":"10.1016\/j.path.2024.04.006_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ajcp\/aqy114","article-title":"Enhanced detection of cervical cancer and precancer through use of imaged liquid-based cytology in routine cytology and HPV cotesting","volume":"150","author":"Austin","year":"2018","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.path.2024.04.006_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cncy.21544","article-title":"Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices","volume":"123","author":"Blatt","year":"2015","journal-title":"Cancer Cytopathol"},{"issue":"4","key":"10.1016\/j.path.2024.04.006_bib13","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/ajcp\/aqaa074","article-title":"Contributions of Liquid-Based (Papanicolaou) Cytology and Human Papillomavirus Testing in Cotesting for Detection of Cervical Cancer and Precancer in the United States","volume":"154","author":"Kaufman","year":"2020","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.path.2024.04.006_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.path.2024.04.006_bib15","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001540","article-title":"The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation","volume":"102","author":"Scarth","year":"2021","journal-title":"J\u00a0Gen Virol"},{"issue":"1","key":"10.1016\/j.path.2024.04.006_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ygyno.2018.12.028","article-title":"Clinical significance of genotyping for human papillomavirus (HPV) 16 18\/45 combined with cytology in cervical exfoliated cells in HPV oncogenic mRNA-positive women","volume":"153","author":"Wang","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.path.2024.04.006_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.11691","article-title":"Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins","volume":"109","author":"Duensing","year":"2004","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.path.2024.04.006_bib18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"zur Hausen","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"10.1016\/j.path.2024.04.006_bib19","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"Kj\u00e6r","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"Suppl 5","key":"10.1016\/j.path.2024.04.006_bib20","doi-asserted-by":"crossref","first-page":"F168","DOI":"10.1016\/j.vaccine.2012.06.045","article-title":"Human papillomavirus, human immunodeficiency virus and immunosuppression","volume":"30","author":"Denny","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.path.2024.04.006_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000357907","article-title":"Human papillomavirus and immunosuppression","volume":"45","author":"Wieland","year":"2014","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.path.2024.04.006_bib22","doi-asserted-by":"crossref","first-page":"k499","DOI":"10.1136\/bmj.k499","article-title":"Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis","author":"Tainio","year":"2018","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.path.2024.04.006_bib23","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1128\/JCM.36.11.3248-3254.1998","article-title":"Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies","volume":"36","author":"Peyton","year":"1998","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.path.2024.04.006_bib24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12885-016-2518-4","article-title":"Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study","volume":"16","author":"Preisler","year":"2016","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.path.2024.04.006_bib25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/JCM.02147-10","article-title":"Aptima HPV E6\/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer","volume":"49","author":"Ratnam","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.path.2024.04.006_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/IGC.0b013e318280f3bc","article-title":"Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection","volume":"23","author":"Nieves","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.path.2024.04.006_bib27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12253-015-0029-2","article-title":"Clinical Performance of APTIMA Human Papillomavirus (HPV) 16 18\/45 mRNA Genotyping Testing for the Detection of Cervical Intraepithelial Neoplasia 3 (CIN3) or Cancer in a Select Group of Chinese Women","volume":"22","author":"Guo","year":"2016","journal-title":"Pathol Oncol Res"},{"issue":"9916","key":"10.1016\/j.path.2024.04.006_bib28","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.path.2024.04.006_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.path.2024.04.006_bib30","doi-asserted-by":"crossref","first-page":"101675","DOI":"10.1016\/j.pmedr.2021.101675","article-title":"Effectiveness and costs of an implemented primary HPV cervical screening programme in Sweden - A population based cohort study","volume":"25","author":"Bergengren","year":"2022","journal-title":"Prev Med Rep"},{"issue":"2","key":"10.1016\/j.path.2024.04.006_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.path.2024.04.006_bib32","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ygyno.2018.04.007","article-title":"The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results","volume":"149","author":"Stoler","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.path.2024.04.006_bib33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.path.2024.04.006_bib34","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jmoldx.2023.09.008","article-title":"Clinical Accuracy of Alinity m HR HPV Assay on Self- versus Clinician-Taken Samples Using the VALHUDES Protocol","volume":"25","author":"Latsuzbaia","year":"2023","journal-title":"J\u00a0Mol Diagn JMD"},{"key":"10.1016\/j.path.2024.04.006_bib38","doi-asserted-by":"crossref","first-page":"200224","DOI":"10.1016\/j.tvr.2021.200224","article-title":"Comparison of Alinity m HPV and cobas HPV assays on cervical specimens in diverse storage media","volume":"12","author":"Jang","year":"2021","journal-title":"Tumour Virus Res"},{"issue":"6","key":"10.1016\/j.path.2024.04.006_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00286-21","article-title":"Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework","volume":"59","author":"Dhillon","year":"2021","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.path.2024.04.006_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01120-19","article-title":"Alinity m HR HPV assay fulfills criteria for human papillomavirus test requirements in cervical cancer screening settings","volume":"58","author":"O\u0161trbenk Valen\u010dak","year":"2019","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.path.2024.04.006_bib41","doi-asserted-by":"crossref","first-page":"104851","DOI":"10.1016\/j.jcv.2021.104851","article-title":"Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening setting","volume":"140","author":"O\u0161trbenk Valen\u010dak","year":"2021","journal-title":"J\u00a0Clin Virol"},{"issue":"RR-05","key":"10.1016\/j.path.2024.04.006_bib42","first-page":"1","article-title":"Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63","author":"Markowitz","year":"2014","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep"},{"issue":"32","key":"10.1016\/j.path.2024.04.006_bib43","doi-asserted-by":"crossref","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.path.2024.04.006_bib44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/diagnostics13020243","article-title":"Updates on HPV Vaccination","volume":"13","author":"Illah","year":"2023","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.path.2024.04.006_bib45","first-page":"48","article-title":"Reduction in HPV 16\/18 prevalence among young women following HPV vaccine introduction in a highly vaccinated district, Japan, 2008-2017","volume":"14","author":"Karube","year":"2019","journal-title":"J\u00a0Rural Med JRM"},{"issue":"2","key":"10.1016\/j.path.2024.04.006_bib46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1158\/1055-9965.EPI-14-0649","article-title":"HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States","volume":"24","author":"Hariri","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.1016\/j.path.2024.04.006_bib47","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3390\/ijerph15071447","article-title":"Prevalence of vaccine type infections in vaccinated and non-vaccinated young women: HPV-IMPACT, a self-sampling study","volume":"15","author":"Jeannot","year":"2018","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"10.1016\/j.path.2024.04.006_bib48","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3390\/vaccines10050748","article-title":"High prevalence of non-vaccinated oncogenic human papillomavirus genotypes in high-grade squamous intraepithelial lesions of the cervix: thought-provoking results of a detailed hpv genotype analysis","volume":"10","author":"Rideg","year":"2022","journal-title":"Vaccines"},{"issue":"10","key":"10.1016\/j.path.2024.04.006_bib49","doi-asserted-by":"crossref","first-page":"e0223612","DOI":"10.1371\/journal.pone.0223612","article-title":"An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway","volume":"14","author":"Enerly","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.path.2024.04.006_bib50","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1080\/21645515.2015.1066948","article-title":"Comparison of HPV prevalence between HPV-vaccinated and non-vaccinated young adult women (20-26 years)","volume":"11","author":"Guo","year":"2015","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.path.2024.04.006_bib51","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.acc.2017.01.004","article-title":"Human Papillomavirus and Its Testing Assays, Cervical Cancer Screening, and Vaccination","volume":"81","author":"Zhu","year":"2017","journal-title":"Adv Clin Chem"},{"issue":"4","key":"10.1016\/j.path.2024.04.006_bib52","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3390\/cancers12041053","article-title":"Self-Collection for Cervical Screening Programs: From Research to Reality","volume":"12","author":"Hawkes","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.path.2024.04.006_bib53","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3390\/cancers15061669","article-title":"HPV-Based Self-Sampling in Cervical Cancer Screening: An Updated Review of the Current Evidence in the Literature","volume":"15","author":"Daponte","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.path.2024.04.006_bib54","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1186\/s12889-021-11554-6","article-title":"Self-collection for HPV-based cervical screening: a qualitative evidence meta-synthesis","volume":"21","author":"Camara","year":"2021","journal-title":"BMC Publ Health"},{"issue":"2","key":"10.1016\/j.path.2024.04.006_bib55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(18)30763-0","article-title":"Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial","volume":"20","author":"Polman","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.path.2024.04.006_bib56","doi-asserted-by":"crossref","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Collaboration on self-sampling and HPV testing. detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.path.2024.04.006_bib57","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ijc.33967","article-title":"Meta-analysis of agreement\/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening","volume":"151","author":"Arbyn","year":"2022","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.path.2024.04.006_bib58","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.3802\/jgo.2022.33.e4","article-title":"Accuracy of human papillomavirus tests on self-collected urine versus clinician-collected samples for the detection of cervical precancer: a systematic review and meta-analysis","volume":"33","author":"Cho","year":"2022","journal-title":"J\u00a0Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.path.2024.04.006_bib59","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/bjc.2013.22","article-title":"Comparing the performance of six human papillomavirus tests in a screening population","volume":"108","author":"Cuzick","year":"2013","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.path.2024.04.006_bib60","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/PGP.0000000000000556","article-title":"HPV 6-associated HSIL\/Squamous Carcinoma in the Anogenital Tract","volume":"38","author":"Liu","year":"2019","journal-title":"Int J Gynecol"},{"issue":"8","key":"10.1016\/j.path.2024.04.006_bib61","first-page":"1189","article-title":"HPV-negative tumors of the uterine cervix","volume":"32","author":"Nicol\u00e1s","year":"2019","journal-title":"Mod"},{"issue":"6","key":"10.1016\/j.path.2024.04.006_bib62","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jasc.2020.04.010","article-title":"HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women\u2019s hospital laboratory","volume":"9","author":"Ashman","year":"2020","journal-title":"J\u00a0Am Soc Cytopathol"},{"issue":"8","key":"10.1016\/j.path.2024.04.006_bib63","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/dc.25146","article-title":"High-grade squamous intraepithelial lesion cervicovaginal paps with negative high-risk HPV testing, a prospective study with histological follow-up","volume":"51","author":"Agoff","year":"2023","journal-title":"Diagn Cytopathol"},{"issue":"3","key":"10.1016\/j.path.2024.04.006_bib64","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jasc.2019.01.001","article-title":"HPV status in women with high-grade dysplasia on cervical biopsy and preceding negative HPV tests","volume":"8","author":"Ge","year":"2019","journal-title":"J\u00a0Am Soc Cytopathol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918124000175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918124000175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T14:32:10Z","timestamp":1723300330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918124000175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1875918124000175"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2024.04.006","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cervical Human Papillomavirus Testing","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2024.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}